Endospan is Granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the NEXUS™ Aortic Arch Stent Graft System. HERZLIA, Israel--(BUSINESS WIRE)--Endospan, a ...
HERZLIA, Israel--(BUSINESS WIRE)--Endospan, a pioneer in endovascular solutions for the Aortic Arch, today announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational ...
TEL AVIV, Israel, April 07, 2026--(BUSINESS WIRE)--Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and ...
Israel's Endospan has received US Food and Drug Administration (FDA) approval for the NEXUS aortic graft stent system, priming the company for the US commercialisation of the aortic arch dysfunction ...
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US Food and Drug Administration (FDA) approval for its NEXUS aortic graft stent ...
Hosted on MSN
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition
Artivion Inc. (NYSE:AORT) said the U.S. Food and Drug Administration has approved the premarket application for the NEXUS Aortic Arch System, a device developed by its partner Endospan Ltd. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Background Fibromuscular dysplasia (FMD) is a non-atherosclerotic vascular disease that affects medium-sized arteries with multifocal (beaded) or focal stenotic lesions, aneurysms, dissections and ...
Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS(R) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results